Mark Muzi
Impact in
-
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Advanced MRI Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- MRI in cancer diagnosis
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
Papers in
-
- Medical Imaging Techniques and Applications 87
- Radiomics and Machine Learning in Medical Imaging 28
- Advanced MRI Techniques and Applications 27
- Radiopharmaceutical Chemistry and Applications 27
- MRI in cancer diagnosis 21
-
- Cancer, Hypoxia, and Metabolism 37
- Co-authors
- David A. Mankoff (68 shared papers)Kenneth A. Krohn (36 shared papers)Alexander M. Spence (41 shared papers)Jeanne M. Link (28 shared papers)Finbarr O’Sullivan (25 shared papers)Lanell M. Peterson (27 shared papers)John R. Grierson (7 shared papers)Michael M. Graham (15 shared papers)
- Journals
- Journal of Nuclear Medicine (15 papers)Journal of Clinical Oncology (7 papers)Clinical Cancer Research (6 papers)Tomography (5 papers)Nuclear Medicine and Biology (5 papers)
- Partner nations
- United StatesIrelandCzechia
In The Last Decade
Mark Muzi
112 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 125
- Radiology, Nuclear Medicine and Imaging 2.9k
- Genetics 1.0k
- Cancer Research 1.3k
- Oncology 760
- Modeling and Simulation 116
Countries citing papers authored by Mark Muzi
This map shows the geographic impact of Mark Muzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Muzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Muzi more than expected).
Fields of papers citing papers by Mark Muzi
This network shows the impact of papers produced by Mark Muzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Muzi. The network helps show where Mark Muzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Muzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 310 | |
| 2 | In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. | 2002 | 255 |
| 3 | 2008 | 216 | |
| 4 | 2015 | 141 | |
| 5 | 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. | 2004 | 137 |
| 6 | 2007 | 132 | |
| 7 | Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. | 2005 | 124 |
| 8 | 2009 | 121 | |
| 9 | 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. | 2004 | 108 |
| 10 | Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas. | 2006 | 105 |
| 11 | 2008 | 103 | |
| 12 | 2009 | 101 | |
| 13 | Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. | 1998 | 100 |
| 14 | The FDG lumped constant in normal human brain. | 2002 | 97 |
| 15 | Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. | 2005 | 92 |
| 16 | 2016 | 85 | |
| 17 | 2011 | 84 | |
| 18 | 2006 | 82 | |
| 19 | 2006 | 77 | |
| 20 | 2012 | 77 |
About Mark Muzi
Mark Muzi is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 116 papers that have together received 4.3k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (87 papers), Cancer, Hypoxia, and Metabolism (37 papers), Glioma Diagnosis and Treatment (31 papers), Radiomics and Machine Learning in Medical Imaging (28 papers), Advanced MRI Techniques and Applications (27 papers), Radiopharmaceutical Chemistry and Applications (27 papers), MRI in cancer diagnosis (21 papers) and Pharmacological Effects and Toxicity Studies (8 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.9k citations), Genetics (1.0k citations), Cancer Research (1.3k citations), Oncology (760 citations) and Modeling and Simulation (116 citations). Mark Muzi has collaborated with scholars based in United States, Ireland and Czechia. Frequent co-authors include David A. Mankoff, Kenneth A. Krohn, Alexander M. Spence, Jeanne M. Link, Finbarr O’Sullivan, Lanell M. Peterson, John R. Grierson, Michael M. Graham, Joseph G. Rajendran and Hubert Vesselle. Their work appears in journals such as Journal of Nuclear Medicine, Journal of Clinical Oncology, Clinical Cancer Research, Tomography and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.